Publications

Journal Article Epublish 101 citations
Electronic publication date
September 26, 2012

View on Pubmed.gov 23006986 | View on doi.org 10.1186/alzrt14...

Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions.

Search for publications in this journal Alzheimers Res Ther - 4(5):41

Abstract

INTRODUCTION

Frontotemporal dementia (FTD) is a common cause of early-onset dementia with a significant genetic component, as underlined by the recent identification of repeat expansions in the gene C9ORF72 as a major cause of FTD and motor neuron disease. Understanding the neurobiology and clinical phenomenology of this novel mutation is currently a major research focus. However, few data are available concerning the longitudinal evolution of this genetic disease. Here we present longitudinal neuropsychological and neuroimaging data on a cohort of patients with pathological repeat expansions in C9ORF72.

METHODS

Following a review of the University College London FTD DNA database, 20 cases were retrospectively identified with a C9ORF72 expansion. Twelve cases had longitudinal neuropsychology data available and six of these cases also had longitudinal volumetric brain magnetic resonance imaging. Cortical and subcortical volumes were extracted using FreeSurfer. Rates of whole brain, hemispheric, cerebellar and ventricular change were calculated for each subject. Nonlinear fluid registration of follow-up to baseline scan was performed to visualise longitudinal intra-subject patterns of brain atrophy and ventricular expansion.

RESULTS

Patients had low average verbal and performance IQ at baseline that became impaired (< 5th percentile) at follow-up. In particular, visual memory, naming and dominant parietal skills all showed deterioration. Mean rates of whole brain atrophy (1.4%/year) and ventricular expansion (3.2 ml/year) were substantially greater in patients with the C9ORF72 mutation than in healthy controls; atrophy was symmetrical between the cerebral hemispheres within the C9ORF72 mutation group. The thalamus and cerebellum showed significant atrophy whereas no cortical areas were preferentially affected. Longitudinal fluid imaging in individual patients demonstrated heterogeneous patterns of progressive volume loss; however, ventricular expansion and cerebellar volume loss were consistent findings.

CONCLUSION

Disease evolution in C9ORF72-associated FTD is linked neuropsychologically with increasing involvement of parietal and amnestic functions, and neuroanatomically with rather diffuse and variable cortical and central atrophy but more consistent involvement of the cerebellum and thalamus. These longitudinal profiles are consistent with disease spread within a distributed subcortical network and demonstrate the feasibility of longitudinal biomarkers for tracking the evolution of the C9ORF72 mutation phenotype.

References

Neurology. 2009 May 26;72(21):1843-9

Lancet Neurol. 2012 Apr;11(4):323-30

Acta Neuropathol. 2011 Dec;122(6):673-90

Neuroimage. 2012 Jul 16;61(4):1402-18

Cited by 101 citations (total)

Journal Article Research Support, Non-U.S. Gov't

Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing.

Electronic publication date June 29, 2016

Search for publications in this journal Acta Neuropathol

Martin H Schludi [...] Dieter Edbauer et al.

A massive expansion of a GGGGCC repeat upstream of the C9orf72 coding region is the most common known cause of...

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence.

Electronic publication date July 7, 2015

Search for publications in this journal Neurology

Corey T McMillan [...] Edward B Lee et al.

OBJECTIVE

To use in vivo neuroimaging and postmortem neuropathologic analysis in C9orf72 repeat expansion patients to investigate the hypothesis that C9orf72...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties